Legal But Still Illegal CLE
Legal, but Still Illegal: The Status of Cannabis Policy in Washington DC & the States



Live Webcast/Rebroadcast – You watch the course online at the specified date and time shown below. You can ask questions and receive answers during the course.

On-Demand – You watch the course anytime and will have access to the course 24/7. Our On-Demand courses are available within 5-10 business days after the original recording and accessible for one year.

Course Description

This program was recorded on July 1, 2020

Medical cannabis has been legal in California for over 20 years. Over the last two decades, a significant number of states have passed laws through citizen-initiated ballot measures and through their legislatures to legalize medical and adult-use cannabis. As of this spring, 33 states have medical cannabis and 11 have adult-use. Notwithstanding these vast steps forward in the issue, the Federal government has yet to address the current classification of cannabis as a Schedule 1 drug, and said classification makes the substance 100% federally illegal. Since the House of Representatives has pivoted to Democrat control, several measures have been introduced to fix the incongruity between state and federal law on cannabis, namely the SAFE Banking Act.

Attorney Melissa KuipersMelissa Kuipers
Dubbed “The Negotiator” by ColoradoBiz Magazine and a “power lobbyist” by Colorado Politics, Melissa Kuipers Blake is a leading lobbyist and seasoned political strategist with more than 20 years of national political experience at the local, state and federal levels of government. Melissa leads negotiations for her clients between elected officials throughout the country and in Washington, D.C., and is known for her issue knowledge, political strategy development and campaign fundraising prowess. When it comes to behind the scenes negotiations and subject matter expertise, Melissa is second to none. In addition to her national lobbying practice, Melissa serves as co-chair of Brownstein’s Cannabis & Industrial Hemp industry group, which helps shape legislative policies for these industries. Having worked on cannabis issues since day one of legalization in Colorado, Melissa has a foundational perspective on the growth of the industry and its players. She regularly shares that expertise from a statutory, regulatory, compliance and workplace perspective.

Contact Melissa Kuipers

1 General Credit

ProLawCLE will seek approval of any CLE program where the registering attorney is primarily licensed with exceptions stated below. Application is made at the time an attorney registers for a course, therefore approval may not be received at the time of broadcasting.

ProLawCLE does not seek approval in the state of Virginia.

Each state has its own governing rules and regulations with regards to CLE courses and formats, therefore please contact your state MCLE regulatory entity for further details about your state’s rules. Please visit our State Requirements page for information regarding your state’s CLE requirements and/or contact information for your state bar.

As stated in our Reciprocity Provision, ProLawCLE will grant credit in the following states through reciprocity, therefore direct application will not be made in these states:

AK, AR, CO, FL, ME, MT, ND, NH, NJ, NY, and PR.

ProLawCLE is dedicated to providing quality education from expert speakers and ensuring each attorney receives CLE credit for their participation. If for some reason a particular course does not receive approval in the attorney’s primary state of licensure, ProLawCLE will give credit for a future approved course or give a full refund, if applicable.

Each On-Demand course is available to you for 1 year from date of purchase. Additionally, CLE credit is only available within that year.

  • Nuts and Bolts of the Legislation
  • Political Realities of this Bill
  • The STATES Act
  • Appropriations Riders
  • Descheduling Bills
  • Other Cannabis-Related Legislation
  • Cannabis in the Age of COVID-19
  • What the Pandemic has Meant for the Industry
  • How the Industry Will Survive This “New Normal” and Beyond